Ginocchio Paul's Insider Trades & SAST Disclosures
Ginocchio Paul's most recent trade in Augmedix Inc was a trade of 6,250 Restricted Stock Units done . Disclosure was reported to the exchange on Aug. 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ginocchio Paul.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Augmedix Inc | Paul Ginocchio | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 6,250 | 87,500 | - | - | Restricted Stock Units | |
| Augmedix Inc | Paul Ginocchio | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 6,250 | 138,146 | - | - | Common Stock | |
| Augmedix Inc | Paul Ginocchio | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.27 per share. | 15 Aug 2024 | 2,351 | 135,795 | - | 2.3 | 5,337 | Common Stock |
| Augmedix Inc | Paul Ginocchio | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 6,250 | 93,750 | - | - | Restricted Stock Units | |
| Augmedix Inc | Paul Ginocchio | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 6,250 | 134,250 | - | - | Common Stock | |
| Augmedix Inc | Paul Ginocchio | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.19 per share. | 15 May 2024 | 2,354 | 131,896 | - | 1.2 | 2,801 | Common Stock |
| Augmedix Inc | Ginocchio Paul | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 100,000 | 100,000 | - | - | Restricted Stock Units | |
| Augmedix Inc | Paul Ginocchio | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2023 | 60,000 | 60,000 | - | - | Employee Stock Option (right to buy) | |
| Augmedix Inc | Paul Ginocchio | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 13 Dec 2022 | 18,000 | 118,000 | - | 1.2 | 21,600 | Common Stock |
| Augmedix Inc | Paul Ginocchio | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 2.96 per share. | 23 Nov 2021 | 14,000 | 82,000 | - | 3.0 | 41,440 | Common Stock |
| Augmedix Inc | Paul Ginocchio | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 28 Oct 2021 | 34,000 | 68,000 | - | 4 | 136,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges